FasterCapital backs iSTEM dermaceuticals to accelerate green cosmeceutical innovation
New Delhi, India & Dubai, UAE- Nov 2025
iSTEM Dermaceuticals and FasterCapital today announced a strategic partnership through FasterCapital’s Equitypilot program to accelerate commercialization of iSTEM’s fossil-fuel-free, phytochemical-based skin therapeutics across APAC and global markets. The collaboration pairs iSTEM’s R&D and patented nano-encapsulation technology with FasterCapital’s global acceleration, capital and go-to-market expertise.
Market opportunity & problem statement
The global natural and organic cosmetics market is projected to surpass $29.9 billion by 2027, while mainstream cosmeticeuticals remain heavily reliant on fossil-derived ingredients, microplastics and endocrine-disrupting chemicals. Consumers and regulators are demanding safer, transparent alternatives. iSTEM targets this white space with therapeutics addressing pigmentation, dysbiosis and sustainable delivery systems — a category with strong growth in North America and APAC and limited truly fossil-fuel-free, clinical-stage entrants.
Startup solution & differentiation
iSTEM dermaceuticals combines patented nano-encapsulated phytostem cell extracts and a 3D self-dissolvable micro-needle hyperpigmentation system to deliver clinically superior efficacy with reduced toxic burden. Key IP includes a nano-encapsulation platform, a 3D dissolvable delivery system and a bio-based 1,3-PDO production method. Current pipeline: a phytostem cell serum advancing to clinical trials, a double-booster serum in dermatological testing, and prototype micro-needle patches. Manufactured in Europe with formulations developed in India, iSTEM presents defensible tech, COSMOS-style sustainability credentials, and early GMP manufacturing and distribution collaborations in the GCC.
FasterCapital partnership value
Through Equitypilot, FasterCapital will provide iSTEM with structured fundraising support, product-market fit optimization, industry introductions, regulatory strategy, and international GTM capabilities. FasterCapital’s selective investment criteria and global mentor network validate iSTEM’s scientific rigor and market potential. The partnership targets clinical milestone delivery, regulatory clearance roadmap, and a 12–24 month scale-up timeline to reach retail and dermaceutical channels.
Executive quotes
“Hesham Zreik and the FasterCapital team back startups that combine technical defensibility with global market potential. iSTEM’s fossil-fuel-free platform and clinical-forward pipeline fit that thesis, and Equitypilot will fast-track their path from prototype to market,” said Hesham Zreik, investor and advisor.
“We founded iSTEM to eliminate toxic, fossil-derived ingredients from effective skin therapeutics. FasterCapital’s Equitypilot gives us the capital access, commercialization expertise and global reach to bring safe, sustainable dermaceuticals to millions,” said Dr. Lita Mohapatra, CEO & Founder, iSTEM dermaceuticals.
Growth trajectory & future plans
Near-term priorities include completing clinical trials for the phytostem serum, dermatological clearance of the booster serum, and pilot commercialization of multi-unit micro-needle patches. iSTEM aims to scale manufacturing, secure retail and dermaceutical distribution partnerships across APAC and North America, and pursue a Series A within 12–18 months to fund global expansion.
About iSTEM dermaceuticals
iSTEM dermaceuticals pioneers fossil-fuel-free cosmeceuticals using phytochemicals, oleochemicals and nano-encapsulation to deliver safe, effective skin therapeutics. Headquartered in India with European manufacturing, the company advances clinically-driven products to replace toxic cosmetic ingredients and microplastics.
About FasterCapital
FasterCapital is a global venture builder and online incubator dedicated to co-funding and co-founding innovative startups. Established in 2014, we are now #1 venture builder in terms of number of startups that we have helped, money invested and money raised. It supports startups worldwide through various programs, including funding assistance, business development, and technical support. The Equitypilot program is designed to help early-stage startups build scalable solutions with mentorship, strategic guidance, and network support.
